Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology
Licensable perturbation dataset to include transcriptomes and proteomic secretomes for understanding the human immune response SEATTLE & MONTREAL — Parse Biosciences, the leading provider of scalable and accessible single-cell sequencing and a QIAGEN company, and Nomic Bio, a leader in high throughput proteomic profiling, today announced their partnership to generate Cascade, a 100 Million cell…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
